Jamy O, Lin K, Worth S, Bachiashvili K, et al. Hypomethylating agent/venetoclax versus intensive chemotherapy in adults with relapsed or refractory acute myeloid leukaemia. Br J Haematol 2022;198:e35-e37.
PMID: 35509246